摘要:
Glycopeptide antibiotics PA-45052 which are produced by Nocardia orientalis PA-45052, show potent activity against gram-positive bacteria, especially against methicillin-resistant bacteria and stimulate growth of animals.
摘要:
A compound of the formula: wherein the wave line means α-bond or β-bond, which compound is useful as a phospholipase A₂ inhibitor. Process for the production of the compound, pharmaceutical composition containing the compound, and a cell culture of a microorganism Thielavia terricola RF-143 producing the compound are also provided.
摘要:
The present invention relates to a novel aldose reductase inhibitor of the formula:
wherein X is methylene or carbonyl; R is
R¹, R², R³, and R⁴ are each hydrogen or lower alkyl, to a method for producing the inhibitor by culturing Crucibulum sp. RF-3817 or its variants, and to an agent for inhibiting an aldose reductase comprising the inhibitor.
摘要:
A compound of the formula (I); wherein R 1 , R 2 , and R 3 are -COOR 4 , -COOR 5 , and -COOR 6 , respectively; R 4 , R 5 , and R 6 , are each hydrogen, lower alkyl, or alkali metal; W is hydroxyl; X, Y, and Z are each hydrogen or hydroxyl; the dotted line indicates the presence or absence of a single bond; and wherein W/R 3 , X/R 1 , and/or Z/R 3 may be combined together, to form a lactone, which compound is useful as a phospholipase A 2 inhibitor. A process for the production of the compound (I), a cell culture of a microorganism Circinotrichum falcatisporum RF-641 producing the same and pharmaceutical compositions containing the same are also provided.
摘要:
A compound of the formula (I); wherein R 1 , R 2 , and R 3 are -COOR 4 , -COOR 5 , and -COOR 6 , respectively; R 4 , R 5 , and R 6 , are each hydrogen, lower alkyl, or alkali metal; W is hydroxyl; X, Y, and Z are each hydrogen or hydroxyl; the dotted line indicates the presence or absence of a single bond; and wherein W/R 3 , X/R 1 , and/or Z/R 3 may be combined together, to form a lactone, which compound is useful as a phospholipase A 2 inhibitor. A process for the production of the compound (I), a cell culture of a microorganism Circinotrichum falcatisporum RF-641 producing the same and pharmaceutical compositions containing the same are also provided.
摘要翻译:式(I)的化合物, 其中,R <1>,R <2>和R <3>是-COOR <4>,-COOR <5>和-COOR <6>,分别; [R <4> - [R <5>和R <6>各自为氢,低级烷基,或碱金属; W是羟基; X,Y和Z各自是氢或羟基; 虚线表示单键的存在或不存在; 和worin W / R <3>中,X / R <1>,和/或Z / R <3>可以结合在一起,以形成内酯,该化合物是作为磷脂酶A2抑制剂是有用的。 本发明提供一种用于生产化合物(I)的过程中,即,微生物Circinotrichum falcatisporum RF-641生产含有相同的相同的和药物组合物的细胞培养物。
摘要:
Glycopeptide antibiotics PA-45052 which are produced by Nocardia orientalis PA-45052, show potent activity against gram-positive bacteria, especially against methicillin-resistant bacteria and stimulate growth of animals.
摘要翻译:由诺卡氏菌PA-45052生产的以下结构的糖肽抗生素PA-45052显示出对革兰氏阳性菌特别是抗甲氧西林抗性细菌的强力活性,并刺激动物的生长。 o